Abstract
Glioblastoma multiforme (GBM) is a malignant brain tumor with a poor long-term prognosis. Despite the aggressive standard of care that includes surgical resection, radiotherapy, and chemotherapy, its highly invasive nature and the high impermeability of the blood-brain barrier (BBB) make it difficult to determine tumor extent and deliver therapeutic agents to the brain appropriately. In a…